MPLT
MapLight Therapeutics, Inc. Common Stock
NASDAQ: MPLT · HEALTHCARE · BIOTECHNOLOGY
$30.70
-3.67% today
Updated 2026-05-01
Market cap
$1.30B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-18.56
Dividend yield
—
52W range
$12 – $33
Volume
0.3M
MapLight Therapeutics, Inc. Common Stock (MPLT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-26.58M | $-52.01M | $-78.81M | $-138.14M |
| Capital expenditures | $746000.00 | $462000.00 | $770000.00 | $473000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | — | — | — | $36.01M |
| Free cash flow | $-27.32M | $-52.47M | $-79.58M | $-138.61M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |